Wolf Popper LLP Announces Investigation on Behalf of Investors in Integra Lifesciences Holding Corporation

PRESS RELEASE
Published May 24, 2023

NEW YORK, NY / ACCESSWIRE / May 24, 2023 / Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Integra Lifesciences Holding Corporation ("Integra") common stock (NASDAQ:IART).

Integra develops regenerative tissue technologies and neurological solutions and has two business segments: Codman Specialty Surgical and Tissues Technologies. Integra has a manufacturing facility in Boston, Massachusetts. The Boston facility generated approximately $78 million of Integra's $1.56 billion 2022 revenues.

Before the market opened on May 23, 2023, Integra announced it initiated a voluntary global recall of all products manufactured in the Boston facility between March 1, 2018 and May 22, 2023 because of higher levels of endotoxins than permitted by the product specifications. Integra also halted production in the Boston facility "to implement additional detection and quality controls." Integra said it expects to incur an impairment charge related to the write-off of inventories, net, of about $22 million and it also lowered its second quarter revenues and adjusted EPS guidance. On this news, Integra's stock price fell $10.24 to $40.48, a drop of 20.2% on very heavy volume.

Investors who have lost over $50,000 trading in Integra's common stock and who would like to discuss the investigation should contact Adam Savett at (212) 451-9655, or asavett@wolfpopper.com.

Wolf Popper has successfully recovered billions of dollars for defrauded investors. Wolf Popper's reputation and expertise have been repeatedly recognized by the courts, which have appointed the firm to major positions in securities litigation. For more information about Wolf Popper, please visit the Firm's website at www.wolfpopper.com.

Attorney Advertising: Prior Results Do Not Guarantee A Similar Outcome.

Contact:

Wolf Popper LLP
Adam Savett
845 Third Avenue
New York, NY 10022
Tel.: (212) 451-9655
Email: asavett@wolfpopper.com

SOURCE: Wolf Popper LLP



View source version on accesswire.com:
https://www.accesswire.com/757078/Wolf-Popper-LLP-Announces-Investigation-on-Behalf-of-Investors-in-Integra-Lifesciences-Holding-Corporation

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.